Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs Pantoprazole for Peptic Ulcer Bleeding
NCT00881413Phase 4Withdrawn
- Sponsor
- Lotung Poh-Ai Hospital
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of esomeprazole in Peptic ulcer hemorrhage (PUB) (2 arms), sponsored by Lotung Poh-Ai Hospital. Primary endpoint: Recurrent bleeding within 14 days of enrollment. Status: withdrawn.
02
Drugs
esomeprazole
03
Conditions
Peptic ulcer hemorrhage (PUB)
Beyond the preview
Go deeper on NCT00881413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00881413.